Lymphoplasmacytic lymphoma (Waldenstrom macroglobulinemia) This is a rare and slow-growing lymphoma. It usually starts in your bone marrow but also can grow in your lymphatic system. Primary ...

Treatment with the novel CAR-T cell therapy was associated with favorable efficacy and safety results in a group of patients with follicular lymphoma, including a few with Waldenstrom ...

I reflect on how cancer has brought out resilience and support in others, even as I struggled with my own battle, and wish ...

Lift for Life Academy supports Tim Basler, a dedicated teacher facing a rare cancer, by raising funds to explore alternative treatments.

Cellectar Biosciences (NASDAQ:CLRB – Get Free Report) will likely be issuing its quarterly earnings data before the market ...

The U.S. Food and Drug Administration granted Fast Track designation to Nurix’s drug candidate NX-5948 for treating relapsed or refractory Waldenstrom’s macroglobulinemia. This designation ...

About Waldenström Macroglobulinemia (WM) WM is a rare, slow growing type of non-Hodgkin's lymphoma that is characterized by ... 4 approximately 12,000 to 19,000 patients are living with Waldenstrom's ...

Beigene is prioritising Waldenstrom’s lymphoma and CLL for the drug’s first registration trials, and it too may be less toxic than Ibrutinib as early data shows less off-target activity with a ...